A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, Marinucci LN, Blight AR, MSF204 Investigators Ann Neurol. 2010 Oct; 68(4):494-502. PMID: 20976768. Abstract CommentRecommendBookmarkWatch